Neumora Therapeutics' shares tumbled more than 80% on Thursday after its experimental depression drug failed to reduce symptoms such as sadness and pessimistic thoughts in a key study, raising ...
Neumora Therapeutics announced that its antidepressant candidate, navacaprant, did not meet the primary endpoint in a Phase 3 study for major depressive disorder.
Here’s how the drugs can affect weight, mood, libido and other functions. By Christina Caron Even if you’ve never taken an antidepressant, you’re probably familiar with the criticism and ...
During pregnancy, a health care provider will generally need to manage two different clinical scenarios: 1) starting medications, either for a woman with new-onset depression or for a woman ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Happy New Year, biotech ...